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What’s Known on This Subject  
Neonatal ECMO survivors are at risk for long-term neuropsychological impairments and school 
problems, while cross-sectional studies have shown intelligence to be average. Despite increased 
awareness of these problems, neonatal ECMO follow-up protocols are not equipped to detect 
these impairments.  
 
What This Study Adds 
Longitudinal evaluation of intelligence in neonatal ECMO survivors shows stable and average 
IQ at 2-5-8 years. School problems following neonatal ECMO are related to worse selective 
attention, irrespective of IQ. Congenital diaphragmatic hernia patients are at highest risk.  
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Abstract 
Objective To assess the longitudinal development of intelligence and its relation to school 
performance in a nationwide cohort of neonatal ECMO survivors as well as evaluate predictors 
of outcome at eight years.  
Methods Repeated measurements of intelligence in neonatal ECMO survivors were collected at 
two, five and eight years (n=178) with validated, standardized instruments. Selective attention 
(n=148) and type of education were evaluated in the eight-year-olds.  
Results Intelligence was found to remain stable and average across development (mean IQ(SD) 
at 2=102(18); at 5=100(17); at 8=99(17)), p=.15. Children attending regular education without 
the need for help (n=101, mean z-score(SD)=-1.50(1.93)) performed significantly better on the 
selective attention task compared to those children in need of extra help (n=65, mean z-
score(SD)=-2.54(3.18)) or those attending special education (n=13, mean z-score(SD)=-
4.14(3.63)), p=.03. However, only children attending special education had below average 
intelligence (mean IQ(SD)=76(15)), compared to average intelligence for those attending regular 
education, both with (mean IQ(SD)=95(15)) and without help (mean IQ(SD)=105(16)). Children 
with congenital diaphragmatic hernia scored significantly lower on both IQ (CDH mean 
IQ(SD)=93(20); MAS mean IQ(SD)=100(15); other diagnoses mean IQ(SD)=100(19), p=.04) 
and selective attention (CDH, mean z-score(SD)=-3.48(3.46)); MAS mean z-score(SD)=-
1.60(2.13); other diagnoses mean z-score(SD)=-1.65(2.39), p=.002) compared to other 
diagnoses.  
Conclusion Intelligence testing alone does not identify those at risk for academic problems for 
the majority of neonatal ECMO survivors. We propose internationally standardized follow-up 
protocols that focus on long-term problem-oriented neuropsychological assessment.  
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Introduction  
Extracorporeal membrane oxygenation (ECMO) has been used in over 28,000 neonates with 
severe respiratory failure who are unresponsive to conventional medical management1. Survival 
rates have remained stable over the years with 5-10% surviving with severe neurological 
complications1. The remaining 90% of survivors are at risk for subtler long-term 
neurodevelopmental problems2-4. Despite increasing awareness of these problems, the current 
standardized (international) follow-up protocols are inadequate for the detection of 
neuropsychological deficits in neonatal ECMO survivors1, 5. As the ELSO recommendations 
have not been reviewed since 1997, an evidence-based update is mandatory6. 
In many follow-up programs, intelligence remains the primary outcome measure5, 6. 
Previous studies have shown intelligence to be comparable to that of healthy children at various 
stages of development2, 3, 7-9.  IQ testing can give valuable insight into the overall cognitive 
functioning of an individual, but is not suited to detect subtle neuropsychological impairments10. 
Extensive neuropsychological testing in neonatal ECMO survivors has demonstrated deficits 
especially in the attention and (working) memory domains in 8- and 17-year-olds2, 4 with an 
increased need for extra help in school2, 4, 8. Since IQ is generally within the average range, the 
school problems are likely due specific neuropsychological impairments. However, this remains 
largely speculative and IQ has not been studied longitudinally.  
In this study, we aimed to investigate the relationship between school problems and 
cognitive outcome in neonatal ECMO survivors. To do so, we first assessed the longitudinal 
development of intelligence at two, five and eight years of age in a nationwide cohort of neonatal 
ECMO survivors. We then evaluated type of education attendance in relation to intelligence and 
to selective attention at eight years of age. Finally, we studied whether school performance and 
cognitive outcome at eight years of age were influenced by clinical characteristics. We 
hypothesized that intelligence is normal across the three ages and unrelated to the school 
problems observed in neonatal ECMO survivors. Based on this, we propose standardized, 
problem-oriented follow-up aimed at specific neuropsychological domains that can be 
internationally implemented.  
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Methods 
Population  
Patients born between January 1996 and December 2006 treated with ECMO within the first 28 
days of life and participating in the structured prospective post-ECMO follow-up program were 
eligible for the current study (n = 278). Children were either part of the follow-up program that 
was initiated in 2001 at the Erasmus MC-Sophia Children’s Hospital in Rotterdam (n = 143) or 
at the Radboud University Medical Centre in Nijmegen initiated in 1998 (n =135). ECMO 
support was given according to the criteria described by Stolar et al11 which did not change over 
time. Entry and exclusion criteria for follow-up were previously described2, 7. The post-ECMO 
follow-up program is the standard of care in the Netherlands2, 7, 12, therefore Institutional Review 
Board approval was waived. Only those children of whom at least the mental developmental 
index at two and IQ at eight years of age were evaluated were included (Rotterdam, n = 96, 
Nijmegen, n = 82) (Figure 1). Demographic and medical characteristics of the patients are 
reported in Table 1. 
 
Neuropsychological assessment  
Intelligence  
Intelligence was measured at two, five and eight years of age. For two-year-olds, the Bailey 
Developmental Scales (BOS 2-30) (n = 100) or, from December 2003, the Bailey Scales of 
Infant Development – Second Edition – Dutch version (BSID-II-NL) (n = 78) were used to 
assess mental outcome. These standardized instruments both assess verbal and non-verbal 
development of 2-to-30 month-old children and are substantially related to each other13.  
The Revised Amsterdam Intelligence Test (RAKIT) short-form was used at five years14. 
For the eight-year-olds, the RAKIT (n = 102) or the Wechsler Intelligence Scale for children 
(WISC-III-NL; n = 76) was used15. Both tests assess verbal and non-verbal intelligence, have 
been shown to have good reliability and validity14, 15, and have been used interchangeably by our 
group before16.  
For all four tests, a normalized population mean of 100 with a standard deviation of 15 is 
used13-15. The outcome on all four tests is referred to as intelligence or IQ.  
 
Selective attention 
Selective attention was measured in the eight-year-old children (n = 148) with the Dot 
Cancellation paper-and-pencil test. The main outcome measure was working-speed, which was 
converted into z-scores (individual score minus the population score divided by the population 
standard deviation). Good validity, sensitivity, reliability and Dutch normative data have been 
reported17.  
 
Procedures and study design 
Children underwent neuropsychological evaluation by a psychologist at two, five and eight years 
of age. Parents filled in questionnaires on ethnicity (Dutch/≥1 non-native Dutch parent) and 
maternal educational level (MEL; high/moderate/low). MEL  refers to the highest type of 
education completed by the mother18. Various medical characteristics were recorded 
prospectively: birth weight, gestational age, diagnosis, age at the start of ECMO, ECMO 
duration/type (venoarterial (VA)/venovenous(VV)/VV conversion to VA), duration of 
mechanical ventilation, extra oxygen supply post extubation, chronic lung disease (CLD; 
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yes/no)19 and abnormal cranial ultrasound (CUS; yes (i.e. parenchymal or intracranial 
bleedings)/no).  
 
Data analysis  
Clinical characteristics of participants and non-participants of the follow-up program were 
compared using independent-samples T-tests for the normally distributed data and Mann-
Whitney U tests for the non-normally distributed data.  
The developmental trajectory of intelligence was evaluated using repeated-measures 
ANOVA. Normality tests were performed. Mauchly’s test was used to assess and correct for 
sphericity. 
  Type of education attendance at eight years of age and its relations to intelligence at two, 
five and eight and selective attention at eight were analyzed using Kruskal-Wallis H tests. For 
post-hoc analyses, the three education categories were transformed into two dummy variables: 1) 
regular education with help versus regular education and special education and 2) special 
education versus regular education with and without help. Independent samples T-tests were then 
conducted to evaluate which groups differed.  
Next, the effect of diagnosis (meconium aspiration syndrome (MAS), congenital 
diaphragmatic hernia (CDH), other diagnoses) on intelligence at all ages, and selective attention 
at eight years were evaluated using Kruskall-Wallis H tests, as previous research has shown 
CDH patients to perform worse compared to children with other diagnoses2.   
Finally, associations between IQ at two years, IQ at five years and outcome at eight years of 
age were evaluated using multivariate linear regression analyses, adjusted for MEL and parents’ 
ethnicity20-22. Parents’ ethnicity was used because a child’s verbal skills, and thus 
neurodevelopmental outcome, may be affected by a parent who was born outside of the 
Netherlands and does not speak Dutch as their first language21. The influence of medical 
characteristics on IQ and selective attention at eight years of age was tested in two separate 
models. Diagnosis, type of ECMO, duration of mechanical ventilation and CLD were added into 
the multivariate linear regression analyses. The assumptions for multivariate linear regression 
analysis were checked with normal probability plots of the residuals and the Durbin-Watson test. 
Multicollinearity was evaluated using the criterion that variance inflation factors could not 
exceed 2.523.  
Analyses were performed with SPSS 22.0 (IBM, Chicago, IL, USA). For all analyses, a p-
value of < .05 was considered statistically significant. 
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Results 
Participants had a significantly higher birthweight than non-participants (mean birthweight (SD) 
= 3461 (552) and 3294 (556) grams respectively; p = .02). No other clinical differences were 
found between participants and non-participants.   
 
Developmental trajectory of intelligence 
Intelligence fell within the normal range at two, five and eight years of age (Figure 2)13-15. 
Mauchly’s test indicated that the assumption of sphericity had been violated (p < .001), therefore 
Greenhouse-Geisser corrected tests are reported (ɛ = .01). Intelligence was found to remain 
stable from two, to five, to eight years of age (p = .15, n = 152). At eight years old, six children 
(3%) had low IQ scores (<70), 39 children (22%) had below average IQ scores (≤85), 103 
children (58%) had average IQ scores (85-115) and 30 children (17%) had an above average IQ 
(≥115). 
 
Outcome and type of education  
Intelligence  
Sixty-five (37%) of the ECMO survivors needed extra help at school at eight years versus 20% 
of children in the general population24. Twelve children (7%) in our cohort attended special 
education at eight years of age (Table 1a), compared to 4.4% in the general population24. To get 
a better understanding of the relatively high proportions of children receiving extra help and 
attending special education, we analyzed its relationship with intelligence. Children attending 
special education had significantly lower intelligence from two years onwards, whereas those 
attending regular education, irrespective of their need for extra help, had comparable intelligence 
to the general population (Table 2).  
 
Selective attention 
The ECMO survivors who attended regular education without help performed significantly better 
on the selective attention task compared to those needing extra help or attending special 
education (p = .02). Selective attention did not significantly differ between the ECMO survivors 
attending special education and those needing extra help (p = .75) (Table 2).  
 
Diagnosis  
Intelligence did not differ at two and five years of age between MAS, CDH or other diagnoses. 
At eight years of age, CDH patients had a significantly lower IQ than those with other diagnoses, 
(p = .04). Furthermore, significant differences were found on selective attention between the 
three diagnostic groups (p = .007), with the CDH group scoring lowest on the selective attention 
task (Table 3).  
 
Predictors of outcome at eight years  
Low MEL increased the likelihood of having a lower IQ at eight years of age. Also, children 
with higher IQ scores at five years of age were more likely to have higher IQ at eight. Having a 
lower IQ score at five years of age increased the likelihood of a poorer score on the selective 
attention task at eight years of age (Table 4).  
None of the medical characteristics were significantly related to outcome at eight years of 
age (Table 4). 
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Discussion 
This is the first longitudinal assessment of IQ in a large group of children treated with neonatal 
ECMO. We showed that intelligence falls within the average range at two, five and eight years of 
age and remains stable. This is in line with previous cross-sectional studies2, 3, 7, 8, 21. Strikingly, a 
large group of children attending regular education needed extra help in school, despite average 
intelligence. We found that these school difficulties were related to selective attention problems. 
As current follow-up protocols focus mainly on IQ, language and visuomotor integration – 
domains that have been shown to remain intact following neonatal ECMO6, 7, 25-27 – those ECMO 
survivors at risk for school problems will not be identified. Our results underline the importance 
of standardized, evidence-based and problem-oriented neuropsychological follow-up following 
neonatal ECMO.  
Despite the fact that the ECMO survivors included in this study did not have severe 
neurological morbidity, twice as many children in our cohort needed extra help at regular 
education compared to the general population24, as previously found by our group2. However, all 
had average intelligence, which did not differ from those who did not need help in school. Also, 
a relatively high number of ECMO survivors attended special education compared to the general 
population24. These children had below average intelligence. Interestingly, both the ECMO 
survivors needing extra help and the ones attending special education performed significantly 
worse on the selective attention task compared to the ECMO survivors not needing help in 
school. Our findings therefore allow us to identify two groups of neonatal ECMO survivors who 
(without overt neurological deficits) are at risk of long-term school problems: those with lower 
IQ and related neuropsychological impairments and those with average IQ but with isolated 
neuropsychological deficits. For children attending special education, poor selective attention is 
more in accordance with – and may be partly explained by – their below average intelligence. 
The combination of which may lead to the need for special education. However, for those 
children needing extra help, isolated neuropsychological deficits may cause the need for 
educational support.  
 For identification of those at risk of school problems, especially of the ECMO survivors 
with average intelligence, problem-oriented neuropsychological assessment that goes beyond 
testing global cognitive functioning with the use of an IQ test10 is essential. Attention and 
(working) memory have been shown to be overlapping constructs that share much of the same 
pathways in the brain29. The attention problems observed in our cohort could therefore be 
accompanied by (working) memory deficits. Indeed, earlier studies have shown 
neuropsychological problems to lie mainly in the attention and memory domains in these 
children2-4, 28. It is therefore highly recommended that besides intelligence, both attention and 
memory, or executive functioning altogether, are focused on following neonatal ECMO. Using 
the current guidelines, neonatal ECMO survivors at risk for school problems will not be 
identified6, 7, 25, 27, 30. We therefore propose a problem-oriented revision of follow-up protocols.   
Since neuropsychological impairments in neonatal ECMO survivors have shown to 
emerge in childhood and to persist even into adolescence2-4, neuropsychological follow-up that 
extends beyond the age of five is crucial6. Neonatal follow-up of premature infants has shown 
early developmental assessments of high-risk infants to often be imprecise – especially for those 
with milder impairments that at a later age do affect their school performance31. It is likely that 
this is similar to neonatal ECMO follow-up. Moreover, neuropsychological testing beyond early 
childhood is important as these types of deficits at a later age may not only continue to hamper 
academic performance, but also affect the ability to participate in society and thus lead a 
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fulfilling life4. However, as we have shown intelligence at five years of age to be highly 
predictive of IQ at eight, elaborate IQ assessment both at five and at eight may be redundant. To 
make most efficient use of time and resources, assessment of a full IQ can be considered at five 
years of age so that specified neuropsychological assessment can be conducted at eight years of 
age. At eight years, IQ can be screened with the use of a few subtests and, only if needed, a full 
IQ test can be administered. Such a problem-oriented approach will make risk stratification and 
early identification of those neonatal ECMO survivors at risk for school problems more feasible.  
Finally, within follow-up of neonatal ECMO survivors, certain risk factors of impaired 
neurodevelopment should be taken into account. IQ at eight years old and selective attention 
were lower in CDH patients compared to children with other underlying diagnoses. These 
findings confirm earlier work demonstrating CDH patients to have generally worse outcomes2. 
Our proposal of problem-oriented and evidence-based neuropsychological follow-up therefore 
seems even more critical for this particular patient group. None of the other clinical 
characteristics studied were found to predict outcome at eight years of age, this is in line with 
previous findings2,4. Low MEL significantly increased the likelihood of lower IQ at eight years 
of age. Although this result is not specific to neonatal ECMO survivors31, 32, it is important to 
take into account during neonatal ECMO follow-up.  
In this nationwide study we are the first to longitudinally assess intelligence in a large 
group of neonatal ECMO survivors. We have identified two specific groups of neonatal ECMO 
survivors who may be at risk for school problems: those with neuropsychological impairments 
despite having average intelligence and those with below average intelligence and 
neuropsychological impairments. As sources for educational support are available for all schools 
in the Netherlands, the number of children needing educational support or special education 
reported in this study are likely to be accurate. Furthermore, due to the high level of compliance, 
selection bias is highly unlikely. Nonetheless, our study has some limitations. First, a Dutch test 
measuring selective attention was used which limits cross-sectional comparisons. On the other 
hand, we were able to compare our data to Dutch normative data. Second, 11% of children 
(n=31) did not complete the neuropsychological assessment at two and/or eight years of age due 
to cognitive or behavioral impairments (n=14, seen elsewhere with severe cognitive impairment 
(i.e. IQ <70); n=11, too tired or uncooperative at time of assessment; n=6, tested elsewhere but 
had average IQ scores), which may have resulted in a bias. However, the percentage of dropouts 
due to severe cognitive impairment was relatively low in comparison to the total number of 
participants, making significant bias unlikely. Third, treatment technologies, especially the use of 
centrifugal pumps, a smaller priming volume and new membranes with subsequently other 
adherence of commonly used drugs, are constantly changing and this may affect long-term 
outcomes. The current findings may thus not be generalizable to patients treated in recent years. 
Future studies should compare outcome between patients treated in different time periods to see 
what the effects of technology changes are in the long-term. Finally, at the time of data 
collection, our neuropsychological follow-up consisted only of intelligence and attention tests. 
Therefore, other cognitive functions that might be susceptible to impairment following neonatal 
ECMO, such as memory and executive functioning4, were not evaluated. Future studies should 
include these cognitive functions when assessing long-term neurodevelopment in neonatal 
ECMO survivors.  
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Conclusion 
Neonatal ECMO survivors have an overall average and stable IQ from two, to five, to eight years 
of age. Despite this, a large group is at risk for school problems. In the majority of ECMO 
survivors at risk, these school problems were related to isolated selective attention deficits. IQ 
alone is therefore not a reliable predictor of school performance or even eventual participation in 
society. As current neonatal ECMO follow-up protocols mainly focus on IQ and language and 
visuomotor integration, those children at risk will not be identified. Our findings emphasize the 
need for evidence-based, problem-oriented neuropsychological follow-up with a focus on 
attention and memory functioning following neonatal ECMO. Taken into account should be risk 
factors such as low MEL and/or a CDH diagnosis. As neuropsychological impairments have 
been shown to emerge in childhood and persist into adolescence, follow-up should extend 
beyond five years of age.  
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Tables  
Table 1. Patient characteristics  
 All (n = 178) MAS (n = 97) CDH (n = 36) Other (n = 45) 
a) Demographic      
Gender     
 Male 96 (54) 46 (47) 24 (67) 26 (58) 
 Female 82 (46) 51 (53) 12 (33) 19 (42) 
Ethnicity      
 Dutch 143 (81) 75 (78) 31 (86) 37 (82) 
 Non-Dutch 34 (19) 21 (22) 5 (14) 8 (18) 
 Unknown 1 1 0 0 
MEL     
 Low 45 (27) 21 (23) 11 (34) 13 (30) 
 Moderate 65 (39) 38 (42) 10 (30) 17 (40) 
 High 56 (34) 31 (35) 12 (36) 13 (30) 
 Unknown 12 7 3 2 
Type of education at 8      
 Regular  100 (56) 58 (60) 18 (51) 24 (53) 
 Regular with help  65 (37) 36 (37) 15 (43) 14 (31) 
 Special education  12 (7) 3 (3) 2 (6) 7 (16) 
 Unknown 1 0 1 0 
b) Clinical  
Birthweight (grms) 3461 (552) 3512 (551) 3316 (436) 3465 (624) 
Gestational age (wks) 40 (2) 41 (2) 39 (1) 39 (2) 
Type of ECMO     
 VA 155 (87) 77 (79) 36 (100) 42 (93) 
 VV 21 (12) 18 (19) 0 (0) 3 (7) 
 VV conversion to VA 2 (1) 2 (2) 0 (0) 0 (0) 
 Unknown 1 0 0 0 
Age start ECMO (dys) 1 (0-23) 1 (0-10) 1 (0-11) 2 (0-23) 
Hours on ECMO 140 (24-369) 135 (24-288) 177 (63-369) 138 (53-288) 
Mechanical vent. (dys) 14 (3-68) 13 (6-32) 28 (7-68) 13 (3-40) 
O2 post-ECMO     
 1 day – 1 week 87 (53) 51 (56) 9 (30) 27 (63) 
 >1 week - <1 month 64 (39) 35 (39) 14 (47) 15 (35) 
 >1 month  13 (8) 5 (5) 7 (23) 1 (2) 
  Unknown 14 6 6 2 
CLD presence     
 Yes 39 (23) 18 (20) 16 (50) 5 (11) 
 No 129 (77) 74 (80) 16 (50) 39 (89) 
 Unknown 10 5 4 1 
Abnormal CUS     
 Yes 17 (10) 6 (6) 2 (6) 9 (20) 
 No 159 (90) 91 (94) 33 (94) 35 (80) 
 Unknown 2 0 1 1 
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N (%) is reported for all demographic variables. Non-Dutch refers to children with at least one 
non-native Dutch parent. The mean (SD) is reported for birthweight and gestational age. The 
median (range) is reported for age start ECMO in days, total amount of hours on ECMO and 
time on mechanical ventilation in days. N (%) was reported for extra oxygen need post-ECMO, 
type of ECMO and CLD presence. Other diagnoses were sepsis (n = 10), persistent pulmonary 
hypertension of the newborn (PPHN; n = 30), pneumonia (n = 2), congenital cystic adenomatoid 
malformation of the lung (n = 1), pneumothorax (n = 1) and infant respiratory distress syndrome 
(n = 1). Abbreviations: MAS, meconium aspiration syndrome; CDH, congenital diaphragmatic 
hernia; MEL; maternal educational level; grms, grams; wks, weeks; dys, days; ECMO, 
extracorporeal membrane oxygenation; O2 post-ECMO, extra oxygen supply post-extubation; 
VA, venoarterial; VV, venovenous; CLD, chronic lung disease; CUS, cranial ultrasound.  
 
 
 
Table 2. Outcome based on type of education attendance at eight years of age 
 MDI 2 yrs 
(n = 178) 
IQ 5 yrs  
(n = 152) 
IQ 8 yrs 
(n = 178) 
Selective attention 8 yrs  
(n = 148) 
Regular education 105 (16) 106 (14) 104 (16) -1.50 (1.93) 
Regular education with help 100 (19) 95 (17) 95 (15) -2.54 (3.18) 
Special education 83 (19)* 81 (15)* 77 (15)* -2.91 (2.21) 
Mean (SD) of MDI/IQ and mean z-score (SD) of selective attention as measured by working speed are 
reported based type of education. Mean z-score (SD) = 0 (1). IQ population mean (SD) = 100 (15).  
*Significantly different IQ score than the general population at p < .001.  
Abbreviations: MDI, mental developmental index; yrs, years.  
 
 
 
Table 3. Neuropsychological outcome based on diagnosis  
 MDI 2 yrs IQ 5 yrs IQ 8 yrs Selective attention 8 yrs 
MAS  104 (18) 101 (14) 100 (15) -1.60 (2.13) 
 n 97 81 97 86 
CDH 98 (18) 98 (21) 93 (20)* -3.48 (3.46)* 
 n 36 32 36 30 
Other   99 (18) 99 (18) 100 (19) -1.39 (1.88) 
 n 45 39 45 32 
Mean (SD) of MDI/IQ and mean z-score (SD) of selective attention as measured by working speed are 
reported based on diagnosis. The IQ population mean = 100 (15). Mean z-score (SD) = 0 (1). 
*Significantly different compared to other diagnostic groups at p < .05.  
Other diagnoses include persistent pulmonary hypertension of the newborn, sepsis, cardinal respiratory 
insufficiency, persistent fetal circulation and respiratory syncytial infection.  
Abbreviations: MDI, mental developmental index; MAS, meconium aspiration syndrome; CDH, 
congenital diaphragmatic hernia; yrs, years.  
 
 
 
 
17 
 
Table 4. Predictors of outcome at eight years.  
 IQ 8 yrs Selective attention 8 yrs 
Demographic predictors  
Low MEL B = -4.72, p = .03 
(CI -8.90 – -0.53) 
B = 0.04, p = .94 
(CI -1.00 – 1.08) 
Dutch ethnicity  B = -1.80, p = .45 
(CI -6.51 – 2.92) 
B = -1.10, p = .09 
(CI -2.27 – 0.15) 
MDI at two  B = 0.07, p = .22 
(CI -0.04 – 0.18) 
B = -0.01, p = .54 
(CI -0.04 – 0.02) 
IQ at five B = 0.75,  p < .001 
(CI 0.63 – 0.88) 
B = -0.07, p < .001 
(CI -0.10 – -0.04) 
Medical predictors 
CDH B = -5.02, p = .25 
(CI -13.65 – 3.62) 
B = 1.31, p = .07 
(CI -0.08 – 2.70) 
MAS B = -0.43, p = .89 
(CI -6.70 – 5.83) 
B = -0.01, p = .98 
(CI -1.04 – 1.02) 
VA B = 2.82, p = .49 
(CI -5.21 – 10.84) 
B = -0.10, p = .87 
(CI -1.27 – 1.08) 
Mech. vent. (days) B = -.19, p = .19 
(CI -0.46 – 0.09) 
B = 0.04, p = .06 
(CI -0.00 – 0.09) 
Multivariate regression analyses to assess the influence of demographic and medical characteristics 
on outcome at eight years of age. Selective attention is measured by working-speed given in 
seconds; a higher score represents slower working-speed and vice versa. MEL (high MEL versus 
low and moderate MEL; low MEL versus high and moderate MEL) and diagnosis (CDH versus rest; 
MAS versus rest) are dummy variables (yes = 1, no = 0). Ethnicity is Dutch (1) or non-Dutch (0).  
A P-value of > .05 was considered statistically significant.  
Abbreviations: yrs, years; MEL, maternal educational level; MDI, mental developmental index; 
CDH, congenital hernia diaphragmatic; MAS, meconium aspiration syndrome; VA ECMO, 
venoarterial extracorporeal membrane oxygenation; CLD, chronic lung disease.  
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Figures 
 
 
Figure 1.  
Inclusion flowchart of the neonatal ECMO survivors.  
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Figure 2.  
Mean (SD) of MDI/IQ was reported at two, five and eight years of age. The population mean IQ 
(SD) = 100 (15). 
Abbreviations: MDI, mental developmental index; IQ, intelligence quotient.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
